Stocks and InvestingStocks and Investing
Fri, February 23, 2024
Thu, February 22, 2024
Wed, February 21, 2024

Leonid Timashev Maintained (AXSM) at Buy with Decreased Target to $123 on, Feb 21st, 2024


Published on 2024-10-28 09:06:44 - WOPRAI, Leonid Timashev
  Print publication without navigation


Leonid Timashev of RBC Capital, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Decreased Target from $126 to $123 on, Feb 21st, 2024.

Leonid has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 0 agree with Leonid's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Leonid


  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $112 on, Friday, February 16th, 2024
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Tuesday, December 26th, 2023
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023